ALESSIO, ENZO
 Distribuzione geografica
Continente #
NA - Nord America 20.374
EU - Europa 12.585
AS - Asia 7.874
SA - Sud America 1.133
AF - Africa 195
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 21
Totale 42.209
Nazione #
US - Stati Uniti d'America 20.157
SG - Singapore 2.987
DE - Germania 2.847
CN - Cina 2.217
SE - Svezia 1.752
UA - Ucraina 1.589
IT - Italia 1.562
RU - Federazione Russa 1.079
GB - Regno Unito 965
HK - Hong Kong 910
BR - Brasile 908
PL - Polonia 827
FI - Finlandia 596
TR - Turchia 559
KR - Corea 360
VN - Vietnam 315
FR - Francia 295
BG - Bulgaria 293
IE - Irlanda 290
IN - India 156
NL - Olanda 133
CA - Canada 129
AR - Argentina 96
CH - Svizzera 82
BD - Bangladesh 54
MX - Messico 53
ES - Italia 51
ID - Indonesia 42
ZA - Sudafrica 42
JP - Giappone 40
EC - Ecuador 39
BE - Belgio 38
SN - Senegal 37
AT - Austria 35
IQ - Iraq 35
MA - Marocco 30
SA - Arabia Saudita 28
EU - Europa 26
EG - Egitto 25
CL - Cile 21
CO - Colombia 21
RO - Romania 21
CI - Costa d'Avorio 19
GR - Grecia 19
CZ - Repubblica Ceca 17
VE - Venezuela 17
JO - Giordania 16
KE - Kenya 16
PT - Portogallo 16
RS - Serbia 16
PK - Pakistan 15
AU - Australia 13
UZ - Uzbekistan 13
AZ - Azerbaigian 11
IR - Iran 11
PY - Paraguay 11
GE - Georgia 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
IL - Israele 9
TH - Thailandia 9
HU - Ungheria 8
NP - Nepal 8
UY - Uruguay 8
DZ - Algeria 7
NZ - Nuova Zelanda 7
TT - Trinidad e Tobago 7
BO - Bolivia 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
SK - Slovacchia (Repubblica Slovacca) 6
TN - Tunisia 6
TW - Taiwan 6
BA - Bosnia-Erzegovina 5
HR - Croazia 5
JM - Giamaica 5
KW - Kuwait 5
MY - Malesia 5
OM - Oman 5
PA - Panama 5
BY - Bielorussia 4
LB - Libano 4
LK - Sri Lanka 4
LV - Lettonia 4
PE - Perù 4
PH - Filippine 4
AL - Albania 3
BH - Bahrain 3
BW - Botswana 3
CR - Costa Rica 3
DK - Danimarca 3
EE - Estonia 3
KG - Kirghizistan 3
NO - Norvegia 3
QA - Qatar 3
SI - Slovenia 3
AO - Angola 2
GH - Ghana 2
GT - Guatemala 2
HN - Honduras 2
Totale 42.177
Città #
Woodbridge 2.419
Ann Arbor 2.344
Fairfield 1.925
Houston 1.766
Singapore 1.623
Jacksonville 1.396
Ashburn 1.326
Chandler 1.136
Wilmington 1.040
Hong Kong 900
Seattle 792
Hefei 767
Cambridge 649
Warsaw 541
Princeton 523
Izmir 494
Beijing 489
Boardman 465
Seoul 358
Trieste 317
Sofia 291
Dublin 281
Munich 268
San Jose 265
Zgierz 257
Columbus 252
Dearborn 222
Santa Clara 195
Los Angeles 188
Dallas 183
Moscow 181
Milan 171
Buffalo 164
Ho Chi Minh City 128
San Diego 124
Helsinki 86
Düsseldorf 84
Redwood City 73
Verona 71
Bern 70
Mcallen 67
São Paulo 66
Chicago 65
Hanoi 62
Frankfurt am Main 59
London 58
The Dalles 54
Nanjing 50
Mestre 49
Phoenix 49
Montréal 48
Des Moines 46
Guangzhou 42
New York 40
Dakar 37
Council Bluffs 36
Norwalk 36
Rio de Janeiro 36
Kocaeli 34
Kunming 33
Shanghai 33
Turku 32
Brussels 29
Tokyo 29
Redondo Beach 28
Chennai 27
Tianjin 26
Casablanca 24
Bremen 23
Rome 23
Montreal 22
San Francisco 21
Andover 20
Jinan 20
Abidjan 19
Denver 19
Nanchang 19
Ottawa 19
Vienna 19
Wuhan 19
Zhengzhou 19
Mexico City 18
Brooklyn 17
Johannesburg 17
Nuremberg 17
Orem 16
Da Nang 15
Falls Church 15
Mumbai 15
Naples 15
North Bergen 15
Porto Alegre 15
Amsterdam 14
Chengdu 14
Lauterbourg 14
Nairobi 14
Shenyang 14
Toronto 14
Atlanta 13
Baghdad 13
Totale 26.566
Nome #
Chimica Inorganica, seconda edizione italiana condotta sulla quinta edizione inglese 602
Neutral 1,3,5-Triaza-7-phosphaadamantane-Ruthenium(II) Complexes as Precursors for the Preparation of Highly Water-Soluble Derivatives 571
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity 362
New Insight into a Deceptively Simple Reaction: The Coordination of bpy to RuII-Carbonyl Precursors - The Central Role of thefac-[Ru(bpy)Cl(CO)3]+Intermediate and theChloride Rebound Mechanism 355
New Cationic and Neutral Ru(II)- and Os(II)-dmso carbonyl Compounds 348
1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for thepreparation of ruthenium complexes with potential anticancer activity 333
Side-to-face ruthenium porphyrin arrays. Photophysical behavior of dimeric and pentameric systems. 283
A noncovalently linked, dynamic fullerene porphyrin dyad. Efficient formation of long-lived charge separated states through complex dissociation. 281
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective 280
null 252
New salts of anionic complexes of Ru(III) as antimetastatic and antineoplastic agents. 251
Palladium complexes with simple iminopyridines as catalysts for polyketone synthesis 251
Design of photoactivatable metallodrugs: Selective and rapid light-induced ligand dissociation from half-sandwich [Ru([9]aneS3)(N–N′)(py)]2+ complexes 240
Synthesis, Molecular Structure and Chemical Behavior of Hydrogen trans-bis(Dimethylsulfoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulfoxide)Ruthenium(III) - the First Fully Characterized Chloride Dimethylsulfoxide Ruthenium(III) Complexes 235
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry 234
A categorization of metal anticancer compounds based on their mode of action. 228
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 227
(15)N NMR spectroscopy unambiguously establishes the coordination mode of the diimine linker 2-(2'-pyridyl)pyrimidine-4-carboxylic acid (cppH) in Ru(II) complexes 227
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 224
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 223
Discrete Supramolecular Assemblies of Porphyrins Mediated by Coordination Compounds 219
Solution and solid state structure of a canted, side-to-face, bis-porphyrin adduct. 218
Rare Example of Stereoisomeric 2 + 2 Metallacycles of Porphyrins Featuring Chiral-at-Metal Octahedral Ruthenium Corners 218
A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin 217
Activation of Rh6(CO)16 with 1,10-phenanthroline and substituted derivatives in the catalytic reduction of nitrobenzene to aniline with carbon monoxide and water 217
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 216
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 216
New atropisomeric bidentate nitrogen-donor compounds as potential stereocontrollers in mild CO-styrene copolymerisation catalysed by palladium(II) salts. 214
Synthesis and characterization of new halogen -tetramethylene sulfoxide-ruthenium(II) and ruthenium(III) complexes; crystal structure of cis-dichlorotetrakis(tetramethylene sulfoxide) ruthenium(II) and hydrogen trans-bis(tetramethylene sulfoxide)tetrachlororuthenate(III) 212
The rare head-to-head conformation of untethered lopsided ligands discovered in both solution and solid states of 1,5,6-trimethylbenzimidazole Re(V) and Ru(II) complexes. 211
The synthesis of RuBr2(DMSO)3 revisited: a mixture of Li[fac-RuClnBr3-n(DMSO)3] isomers (n = 0-3) is the reaction product 209
Activation of carbonyl clusters with 1,10-phenanthroline and related ligands: the reduction of nitrobenzene as a model reac¬tion for MX(CO)Y (M = Ru, Os, Ir) + Phen systems as catalyst precursors 208
Ruthenium(III) complexes as antineoplastic agents. 207
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 207
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 207
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 207
A novel open-box shaped pentamer of vertically linked porphyrins that selectively recognizes S-bonded Me2SO complexes. 206
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 206
Synthesis and Properties of Novel Fullerene Derivatives 204
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 204
Carbonyl derivatives of chloride dimethyl-sulfoxide ruthenium(II) complexes. Synthesis, structural characterization, and reactivity of Ru(CO)(X)(Dmso)(4-X)Cl-2 complexes (X=1-3) 203
Ruthenium anticancer compounds: challenges and expectations 202
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 200
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media 196
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 196
Chemical properties of rare platinum metal complexes having antitumor activity 196
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 195
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity. 195
Porphyrin "flying saucers": Solid state and solution structure of a novelpentameric array of axially-ligated canted porphyrins. 193
NMR structural characterization of the reaction product between d(GpG) and the octahedral antitumor complex trans-RuCl2(DMSO)4. 193
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 193
Crystals containing conformers: a rare case in which a solid closely reflects a solution equilibrium mixture 192
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 191
Wavelength-Dependent Electron and Energy Transfer Pathways in a Side-to-Face Ruthenium Porphyrin / Perylene Bisimide Assembly 190
Synthesis, structural characterization and chemical behavior of new dimeric Ru(III) complexes 190
Complexed bridging ligands: oxorhenium(V) compounds with mono-coordinated pyrazine or pyrimidine as possible building-blocks for the construction of polynuclear architectures. 189
Antileukemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukemia and on P388/DDP subline 189
Novel Ru(III)-dimethyl sulfoxide catalysts for the selective oxidation of thioethers to sulfoxides with molecular oxygen 188
Structure of trans-dichlorotetrakis(dimethyl sulfoxide)rhodium(III) tetrafluoroborate 188
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 188
Water-Soluble Ruthenium(II) Carbonyls with 1,3,5-Triaza-7-phosphoadamantane 188
Photolabile Ru Model Complexes with Chelating Diimine Ligands for Light-Triggered Drug Release 188
Complessi trans di rutenio come agenti antineoplastici 187
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 187
Synthesis and characterization of a new series of palladium(II) compounds with nitrogen-donor chelating ligands: [Pd(chel)(L)2][PF6]2 187
Coordination and release of NO by ruthenium-dimethylsulfoxide complexes - implications for anti-metastases activity. 186
Phototoxic Activity and DNA Interactions of Water-Soluble Porphyrins and Their Rhenium(I) Conjugates 186
Factors that influence the antiproliferative activity of half sandwich RuII-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. 185
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 184
Free exchange across cells,and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A(imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate)ON KB Tumor cells. 184
A Functionalized Noncovalent Macrocyclic Multiporphyrin Assembly from a Dizinc(II) Bis-Porphyrin Receptor and a Free-Base Dipyridylporphyrin 184
Complessi di Rutenio con elevata attività antitumorale 183
Geometrical and linkage isomers of OsCl2(dmso)4: the complete picture 183
Energy Transfer Pathways in Pyridylporphyrin Re(I) Adducts. 182
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 182
Two-point self-coordination of a dizinc(ii) bis-pyridylporphyrin ruthenium complex leading selectively to a discrete molecular assembly: solution and solid state characterization 182
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 181
Mixed-ligand rhenium(V) oxo monomers with triphenylphosphine oxide and lopsided and symmetrical heterocyclic ligands. Putative intermediates in rhenium(V) oxo synthetic chemistry 180
The interaction of the antitumor complexes Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)] with apotransferrin: a spectroscopic study 180
Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity? The development of new Ru(II)-[9]aneS3 analogues. 179
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 179
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 179
Selective hydrogen transfer reactions from alcohols to ketones promoted by rhodium complexes with 1,10-phenanthroline and related ligands 179
Metal-mediated multi-porphyrin discrete assemblies and their photoinduced properties. 177
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 176
Novel Ruthenium Building Blocks for the Efficient Modular Construction of Heterobimetallic Molecular Squares of Porphyrins 176
Carbonyl derivatives of chloride-dimethyl sulfoxide-ruthenium(III) complexes. Synthesis, crystal-structure, and reactivity of [(Dmso)(2)H][Trans-RuCl4(Dmso)(CO)] and mer, cis-RuCl3(Dmso)(2)(CO) 175
Towards Matched Pairs of Porphyrin-ReI/99mTcIConjugates that Combine Photodynamic Activity with Fluorescence and Radio Imaging 174
Photo-active triads self-assembled around a pivot aluminum(III)porphyrin 174
Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties 174
Sistemi periodici: una proposta didattica interdisciplinare tra chimica e letteratura 174
The first example of a double bridged diruthenium(II) complex containing the rare bridging S,O bidentate dimethyl sulfoxide ligand which defines a stable Ru-Cl-Ru-S-O five-membered ring. 173
Synthesis and characterization of two new classes of ruthenium(III)-sulfoxide complexes with nitrogen donor ligands (L): Na[trans-RuCl4(R2SO)(L)] and mer,cis-RuCl3(R2SO)(R2SO)(L). The crystal structure of Na[trans-RuCl4(DMSO)(NH3)]•2DMSO, Na[trans-RuCl4(DMSO)(Im)]•H2O•Me2CO (Im = imidazole) and mer,cis- RuCl3(DMSO)(DMSO)(NH3) 173
The concept of prochirality applied to coordination compounds 173
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an antimetastatic ruthenium complex 172
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds Na2[{trans-RuCl4(Me2SO)}2(μ-L)] (L=ditopic, non-chelating aromatic N-ligand). A preliminary investigation 172
New geometrical and linkage isomers of the Ru(II) precursor cis,cis,trans-RuCl2(dmso-S)2(dmso-O)(CO): a spectroscopic and structural investigation 172
Bioinorganic Medicinal Chemistry 171
The Deceptively Similar Ruthenium(III) Drug Candidates KP1019 and NAMI-A Have Different Actions. What Did We Learn in the Past 30 Years? 171
Ru(ii)-Peptide bioconjugates with the cppH linker (cppH = 2-(2'-pyridyl)pyrimidine-4-carboxylic acid): synthesis, structural characterization, and different stereochemical features between organic and aqueous solvents 171
Totale 21.260
Categoria #
all - tutte 122.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.790 0 0 0 0 0 0 267 358 176 406 156 427
2021/20223.140 146 232 197 419 70 224 94 125 355 298 213 767
2022/20233.639 373 433 264 440 436 688 32 289 433 23 169 59
2023/20241.907 173 139 91 165 194 107 206 493 15 33 167 124
2024/20255.099 84 311 470 454 463 490 458 373 564 462 369 601
2025/20266.350 957 831 1.091 1.064 933 1.190 284 0 0 0 0 0
Totale 43.051